{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:24Z","timestamp":1772166264051,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,14]]},"DOI":"10.7759\/cureus.66880","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T19:28:26Z","timestamp":1723663706000},"source":"Crossref","is-referenced-by-count":2,"title":["Incidence and Predictors of Unexpected Malignancy in Benign Myomectomy or Hysterectomy"],"prefix":"10.7759","author":[{"given":"Fatema Y","family":"Sabt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan M","family":"Isa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra A","family":"Khudair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enjy E","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatema A","family":"Alkhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumana S","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.02.051","article-title":"Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy","volume":"221","author":"Desai VB","year":"2019","unstructured":"Desai VB, Wright JD, Gross CP, et al.. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy. Am J Obstet Gynecol. 2019, 221:39.e1-39.e14. 10.1016\/j.ajog.2019.02.051","journal-title":"Am J Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.20199","article-title":"Risk of incidental genital tract malignancies at the time of myomectomy and hysterectomy for benign conditions","volume":"64","author":"Yadav G","year":"2021","unstructured":"Yadav G, Rao M, Goyal SB, Singh P, Kathuria P, Gothwal M. Risk of incidental genital tract malignancies at the time of myomectomy and hysterectomy for benign conditions. Obstet Gynecol Sci. 2021, 64:209-15. 10.5468\/ogs.20199","journal-title":"Obstet Gynecol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0361","article-title":"Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma","volume":"20","author":"Brohl AS","year":"2015","unstructured":"Brohl AS, Li L, Andikyan V, et al.. Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma. Oncologist. 2015, 20:433-9. 10.1634\/theoncologist.2014-0361","journal-title":"Oncologist"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.11.1086","article-title":"Incidence of sarcoma in patients undergoing hysterectomy for benign indications: A population-based study","volume":"220","author":"Multinu F","year":"2019","unstructured":"Multinu F, Casarin J, Tortorella L, et al.. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: A population-based study. Am J Obstet Gynecol. 2019, 220:179.e1-179.e10. 10.1016\/j.ajog.2018.11.1086","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266338","article-title":"Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review","volume":"17","author":"Elliott CG","year":"2022","unstructured":"Elliott CG, Murji A, Matelski J, Adekola AB, Chrzanowski J, Shirreff L. Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review. PLoS One. 2022, 17:e0266338. 10.1371\/journal.pone.0266338","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2017.06.029","article-title":"Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications","volume":"216","author":"Lange S","year":"2017","unstructured":"Lange S, Pluchino N, Fehlmann A, et al.. Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications. Eur J Obstet Gynecol Reprod Biol. 2017, 216:239-44. 10.1016\/j.ejogrb.2017.06.029","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10397-015-0894-4","article-title":"The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: A meta-analysis","volume":"12","author":"Pritts EA","year":"2015","unstructured":"Pritts EA, Vanness DJ, Berek JS, Parker W, Feinberg R, Feinberg J, Olive DL. The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: A meta-analysis. Gynecol Surg. 2015, 12:165-77. 10.1007\/s10397-015-0894-4","journal-title":"Gynecol Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0b013e31829ff5b8","article-title":"Unanticipated uterine pathologic finding after morcellation during robotic-assisted supracervical hysterectomy and cervicosacropexy for uterine prolapse","volume":"20","author":"Hill AJ","year":"2014","unstructured":"Hill AJ, Carroll AW, Matthews CA. Unanticipated uterine pathologic finding after morcellation during robotic-assisted supracervical hysterectomy and cervicosacropexy for uterine prolapse. Female Pelvic Med Reconstr Surg. 2014, 20:113-5. 10.1097\/SPV.0b013e31829ff5b8","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.01.012","article-title":"A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature","volume":"212","author":"Liu FW","year":"2015","unstructured":"Liu FW, Galvan-Turner VB, Pfaendler KS, Longoria TC, Bristow RE. A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature. Am J Obstet Gynecol. 2015, 212:717-24. 10.1016\/j.ajog.2015.01.012","journal-title":"Am J Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002521","article-title":"Occult gynecologic cancer in women undergoing hysterectomy or myomectomy for benign indications","volume":"131","author":"Desai VB","year":"2018","unstructured":"Desai VB, Wright JD, Schwartz PE, et al.. Occult gynecologic cancer in women undergoing hysterectomy or myomectomy for benign indications. Obstet Gynecol. 2018, 131:642-51. 10.1097\/AOG.0000000000002521","journal-title":"Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04343-0","article-title":"The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications","volume":"149","author":"Ding Y","year":"2023","unstructured":"Ding Y, Han Y, Zhang S, Shi X. The incidence of unexpected uterine malignancies in hysterectomies carried out for benign indications. J Cancer Res Clin Oncol. 2023, 149:4339-45. 10.1007\/s00432-022-04343-0","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000642","article-title":"Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications","volume":"125","author":"Mahnert N","year":"2015","unstructured":"Mahnert N, Morgan D, Campbell D, Johnston C, As-Sanie S. Unexpected gynecologic malignancy diagnosed after hysterectomy performed for benign indications. Obstet Gynecol. 2015, 125:397-405. 10.1097\/AOG.0000000000000642","journal-title":"Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2019.101631","article-title":"Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma","volume":"49","author":"Yorganc\u0131 A","year":"2020","unstructured":"Yorganc\u0131 A, Meydanl\u0131 MM, Kad\u0131o\u011flu N, et al.. Incidence and outcome of occult uterine sarcoma: A multi-centre study of 18604 operations performed for presumed uterine leiomyoma. J Gynecol Obstet Hum Reprod. 2020, 49:101631. 10.1016\/j.jogoh.2019.101631","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2019.08.003","article-title":"Incidence of occult malignancies identified during hysterectomies performed for benign indications","volume":"49","author":"Topdagi Yilmaz EP","year":"2020","unstructured":"Topdagi Yilmaz EP, Cimilli Senocak GN, Topdagi YE, Aynaoglu Yildiz G, Kumtepe Y. Incidence of occult malignancies identified during hysterectomies performed for benign indications. J Gynecol Obstet Hum Reprod. 2020, 49:101620. 10.1016\/j.jogoh.2019.08.003","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2018.03.075","article-title":"The incidence of occult malignancy following uterine morcellation: A ten-year single institution experience retrospective cohort study","volume":"53","author":"Mori KM","year":"2018","unstructured":"Mori KM, Abaid LN, Mendivil AA, et al.. The incidence of occult malignancy following uterine morcellation: A ten-year single institution experience retrospective cohort study. Int J Surg. 2018, 53:239-42. 10.1016\/j.ijsu.2018.03.075","journal-title":"Int J Surg"},{"key":"ref16","article-title":"Uterine smooth muscle tumors of uncertain malignant potential (STUMP): Pathology, follow-up and recurrence","volume":"7","author":"Dall'Asta A","year":"2014","unstructured":"Dall'Asta A, Gizzo S, Musar\u00f2 A, et al.. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): Pathology, follow-up and recurrence. Int J Clin Exp Pathol. 2014, 7:8136-42.","journal-title":"Int J Clin Exp Pathol"},{"key":"ref17","unstructured":"Royal College of Obstetricians and Gynecologists. The Management of Ovarian Cysts in Postmenopausal Women. Green-Top Guideline No. 34. (2016). Accessed. October 22nd, 2023: https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/ovarian-cysts-in-postmenopausal-women-green...."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.09.027","article-title":"Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas","volume":"230","author":"Chen Q","year":"2018","unstructured":"Chen Q, Shi H, Lu W, Lu B. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas. Eur J Obstet Gynecol Reprod Biol. 2018, 230:85-9. 10.1016\/j.ejogrb.2018.09.027","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/281039-incidence-and-predictors-of-unexpected-malignancy-in-benign-myomectomy-or-hysterectomy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T19:28:30Z","timestamp":1723663710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/281039-incidence-and-predictors-of-unexpected-malignancy-in-benign-myomectomy-or-hysterectomy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.66880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}